Class 4 Drug Alert: Actilyse (alteplase)

The MHRA has issued a Class 4 (Caution in Use) Drug Alert for Actilyse 20mg and 50mg powder and solvent for solution for injection and infusion (alteplase).

There have been an increased number of complaints where the rubber stopper has been pushed into the vial during reconstitution. This renders the vial unusable.

Users who experience this issue are asked to report to Boehringer Ingleheim Medical Information on 01344 742579 or medinfo.bra@boehringer-ingelheim.com

Full details are available via the MHRA.


Latest discussions

  1. Are pharmacists guinea pigs for covid19

    Looks like we are! Surgeries and dentist...

  2. Are pharmacists guinea pigs for covid19

    I agree we work behind screens, but that...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.